Instrument Inactif

Autres langues Cynosure, Inc.

Actions

US2325772059

Equipement et technologie médicale avancés

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Autres langues

16/02/17	Brower Piven Commences An Investigation Into The Proposed Sale Of Cynosure, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
16/02/17	CYNOSURE, INC. Former SEC Attorney Willie Briscoe Believes the Acquisition by Hologic, Inc. May be Unfair to Shareholders
15/02/17	Harwood Feffer LLP : Announces Investigation of Cynosure, Inc.
15/02/17	Brower Piven Commences An Investigation Into The Proposed Sale Of Cynosure, Inc. And Encourages Investors To Contact The Firm For Additional Information
15/02/17	CYNOSURE, INC. Rigrodsky & Long, P.A. Announces Investigation Of Buyout
14/02/17	CYNOSURE (CYNO) Alert: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Cynosure, Inc.
14/02/17	Cynosure : Hologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Two Complementary Businesses
07/02/17	Cynosure : Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year
06/01/17	Cynosure : to Host Fourth-Quarter 2016 Financial Results Conference Call on February 7
05/12/16	Cynosure : Recognized Among Deloitte's 2016 Technology Fast 500(TM)
29/11/16	Cynosure : Receives CFDA Clearance to Market the Icon™ Aesthetic System in China
29/11/16	Cynosure : Receives CFDA Clearance to Market the Icon(TM) Aesthetic System in China
10/11/16	Cynosure : to Participate in Stifel 2016 Healthcare Conference
25/10/16	Cynosure : Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million
11/10/16	Cynosure : To Host Third-Quarter 2016 Financial Results Conference Call On October 25
30/09/16	Cynosure : Recognized as One of FORTUNE's 100 Fastest-Growing Companies
13/09/16	Cynosure : to Name Stephen J. Webber as New Chief Financial Officer
26/07/16	Cynosure : Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016
26/07/16	Cynosure : Receives Approval to Market SculpSure® in South Korea
23/07/16	Cynosure : To Host Second-Quarter 2016 Financial Results Conference Call On July 26
14/07/16	Cynosure : To Host Second-Quarter 2016 Financial Results Conference Call On July 26
13/07/16	Cynosure : Receives Health Canada Authorization to Market SculpSure®
16/06/16	Cynosure : to Ring NASDAQ Stock Market Closing Bell to Celebrate 25 Year Anniversary
25/05/16	Cynosure : Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer
24/05/16	Cynosure : Receives FDA Clearance to Market New PicoSure® Energy Delivery System for Tattoos and Pigmented Lesions